BioSpace News Archive

Regenerative Medicine Market is anticipated to Touch USD 60.08 Bn by 2030

Latest Study on “Regenerative Medicine Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

August 18, 2022
·
8 min read
Oxitec Completes Successful Scale-Up of Next-Generation Friendly™ Mosquito Technology in Brazil Designed to Accelerate Global Impact Against Disease-Spreading Invasive Pests

Oxitec Ltd announced the conclusion of the first phase of a project dedicated to large-scale validation of the company’s next-generation Friendly™ Aedes aegypti technology.

August 18, 2022
·
4 min read
Hyperhidrosis Treatment Market Research on Size, Leading Players and Growth Forecast To 2027

According to the current analysis of Reports and Data, the global hyperhidrosis treatment market was valued at USD 1.27 Billion in 2019 and is expected to reach USD 2.10 Billion by the year 2027, at a CAGR of 6.0%.

August 18, 2022
·
8 min read
Mycoplasma Testing Market Geographical Outlook, Recent Developments and Industry Outlook till 2027

According to the current analysis of Reports and Data, the global Mycoplasma Testing market was valued at USD 609.39 Million in 2019 and is expected to reach USD 1.59 Billion by year 2027, at a CAGR of 12.6%.

August 18, 2022
·
7 min read
Biotech Beach

Monkeypox Is an STD, No More Time to Waste, Says AHF

AIDS Healthcare Foundation (AHF) today is calling for monkeypox to be treated as, and formally classified as a sexually transmitted infection (STI).

August 18, 2022
·
3 min read
Business

Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction

Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies, today reported financial results for the second quarter of 2022.

August 18, 2022
·
11 min read
Biotech Bay

Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Iridex Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

August 18, 2022
·
1 min read
Biotech Beach

Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

August 18, 2022
·
1 min read
Lone Star Bio

Aeglea BioTherapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Pegzilarginase for the Treatment of Arginase 1 Deficiency

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), today announced that a Marketing Authorization Application (MAA) for pegzilarginase for the treatment of Arginase 1 Deficiency (ARG1-D) has been submitted to and successfully validated by the European Medicines Agency (EMA).

August 18, 2022
·
5 min read
Business

Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), will announce its second quarter 2022 financial results after market close on Thursday, August 25, 2022.

August 18, 2022
·
3 min read